Viewing StudyNCT00189670



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00189670
Status: COMPLETED
Last Update Posted: 2005-09-19
First Post: 2005-09-12

Brief Title: Randomized Phase II Trial of Dose Dense Docetaxel in N Breast Cancer
Sponsor:
Organization: Association Européenne de Recherche en Oncologie

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: None
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: